Cat. No.: X24-06-ZQ175
c-Ret inhibitor Amuvatinib hydrochloride, Purity ≥98%
Synonym: 1055986-67-8; c-Ret inhibitor; MP470 hydrochloride; MP 470; MP-470; HPK 56 hydrochloride; HPK56; HPK-56
- CAS Number: 1055986-67-8
- Compound CID: 16058702
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Properties
Description
Amuvatinib hydrochloride primarily acts by blocking the ATP-binding site of the kinase domain of the RET protein, thereby inhibiting its autophosphorylation. It targets c-Kit (D816H), c-Kit (D816V), c-Kit (V560G), c-Kit (V654A), PDGFRα (D842V), and PDGFRα (V561D).
Molecular Formula
C23H21N5O3S.xHCl
Targets
c-Kit (D816H): 10 nM; c-Kit (D816V): 950 nM; c-Kit (V560G): 34 nM; c-Kit (V654A): 127 nM; PDGFRα (D842V): 81 nM; PDGFRα (V561D): 40 nM
Identity
Confirmed by NMR/HPLC/MS.
Applications
Amuvatinib hydrochloride serves as a c-Ret inhibitor used in researching targeted cancer therapies, particularly for tumors with c-Ret mutations.
Related Products
Quick Links
